Gilead Sciences has signed non-exclusive license agreements to provide generic versions of tenofovir disoproxil fumarate (sold by Gilead under the brand name Viread) to three generic manufacturers in India. These license agreements grant to Emcure Pharmaceuticals, Hetero Drugs and Strides Arcolab the rights to produce and distribute generic versions of tenofovir to 95 low-income countries around the world, including India. The license agreements require that the generic manufacturers meet c...